Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 45 Neoplasms 6 Colorectal Neoplasms 5 Neoplasm Metastasis 4 Adenocarcinoma 3 Resectable Pancreatic Cancer 2 Rectal Neoplasms 2 Pancreatic Cancer Metastatic 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Urachal cancer 1 Stomach Neoplasms 1 Pancreatic Ductal Adenocarcinoma (PDAC) 1 Pancreatic Cancer Non-resectable 1 Pancreatic Adenocarcinoma 1 Neoplasms, Basal Cell 1 Locally Advanced Unresectable or Metastatic Solid Tumors 1 Locally Advanced Pancreatic Adenocarcinoma 1 Localized Pancreatic Adenocarcinoma 1 Gastrointestinal Neoplasms 1 Gastroesophageal Adenocarcinoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1 Carcinoma, Islet Cell 1 Carcinoma 1 Borderline Resectable Pancreatic Cancer 1

Interventions

Gemcitabine 113 Cisplatin 77 Oxaliplatin 46 pembrolizumab 35 Fluorouracil 33 Capecitabine 31 durvalumab 27 Leucovorin 27 lenvatinib 26 Magnetic Resonance Spectroscopy 15 Irinotecan 14 Drug Therapy 13 Biopsy 13 Nivolumab 12 Albumin-Bound Paclitaxel 12 tislelizumab 11 Specimen Handling 11 Radiofrequency Ablation 11 130-nm albumin-bound paclitaxel 11 pemigatinib 10 apatinib 10 Taxes 10 Radiotherapy 10 Floxuridine 10 Folfox protocol 9 Bevacizumab 9 S 1 (combination) 8 Platinum 8 Photochemotherapy 8 Liver Transplantation 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cholangiocarcinoma × folfirinox × Clear all

NCT02456714 2020-03-10

4CC

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Completed

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡